Kroma Ti D, Inc. announced it raised $7.86 Million in an initial filing from an offering of $10 Million

Company

Location

About

KromaTiD supports research teams in academia, large pharmaceutical, and therapeutic companies with expert scientific support and unparalleled genomics tools and services. We are your partner for biomarker discovery, genotoxicity studies, clone screening assessment of editing-associated errors, and plasmid manufacturing.